Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists

Psychopharmacology

Volumn 219, Issue 2, 2012, Pages 341-352

  Fernando, Anushka B P ^a   Economidou, Daina ^a   Theobald, David E ^a   Zou, Mu Fa ^b   Newman, Amy H ^b   Spoelder, Marcia ^a   Caprioli, Daniele ^a   Moreno, Margarita ^c   Hipólito, Lucia ^d   Aspinall, Albert T ^e   Robbins, Trevor W ^a   Dalley, Jeffrey W ^a,f  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c UNIVERSITY OF ALMERÍA   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

^e UNIVERSITY OF ST ANDREWS   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Atomoxetine; Dopamine; Five choice serial reaction time task; GBR 12909; Guanfacine; Impulsivity; Methylphenidate; Noradrenaline; Quinpirole; Sumanirole

Indexed keywords

ATOMOXETINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; GUANFACINE; METHYLPHENIDATE; NORADRENALIN; QUINPIROLE; SUMANIROLE; VANOXERINE;

ANIMAL EXPERIMENT; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FIVE CHOICE SERIAL REACTION TIME TASK; IMPULSE CONTROL DISORDER; IMPULSIVENESS; LATENT PERIOD; LOW DRUG DOSE; MALE; MENTAL TASK; NEUROMODULATION; NEUROPHARMACOLOGY; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RAT; RESPONSE TIME; TASK PERFORMANCE;

ADRENERGIC AGONISTS; ANIMALS; ANIMALS, OUTBRED STRAINS; ATTENTION; BENZIMIDAZOLES; CHOICE BEHAVIOR; DOPAMINE AGONISTS; GUANFACINE; IMPULSIVE BEHAVIOR; MALE; METHYLPHENIDATE; PIPERAZINES; PROPYLAMINES; QUINPIROLE; RATS; REACTION TIME; SERIAL LEARNING;

EID: 84856667349     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2408-z     Document Type: Article

References (58)

1. AF Arnsten L Scahill RL Findling 2007 Alpha2-adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data J Child Adolesc Psychopharmacol 17 4 393 406 17822336 10.1089/cap.2006.0098
2. MJ Bannon JF Reinhard EB Bunney RH Roth 1982 Unique response to antipsychotic drugs is due to absence of terminal autoreceptors in mesocortical dopamine neurones Nature 296 5856 444 446 7063040 10.1038/296444a0 1:CAS:528:DyaL38XltVCjurY%3D (Pubitemid 12108526)
3. A Bari JW Dalley TW Robbins 2008 The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats Nat Protoc 3 759 767 18451784 10.1038/nprot.2008.41 1:CAS:528:DC%2BD1cXltlSgs7k%3D (Pubitemid 351639020)
4. D Belin AC Mar JW Dalley TW Robbins BJ Everitt 2008 High impulsivity predicts the switch to compulsive cocaine-taking Science 320 5881 1352 1355 18535246 10.1126/science.1158136 1:CAS:528:DC%2BD1cXmslWgur0%3D (Pubitemid 351929473)
5. M Benoit-Marand E Borrelli F Gonon 2001 Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo J Neurosci 21 23 9134 9141 11717346 1:CAS:528:DC%2BD3MXoslyis70%3D (Pubitemid 33096856)
6. M Besson D Belin R McNamara DE Theobald A Castel VL Beckett BM Crittenden, et al. 2010 Dissociable control of impulsivity in rats by dopamine D2/3 receptors in the core and shell subregions of the nucleus accumbens Neuropsychopharmacology 35 2 560 569 19847161 10.1038/npp.2009.162 1:CAS:528:DC%2BD1MXhsFGmsrjL
7. J Biederman T Spencer 1999 Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder Biol Psychiatry 46 1234 1242 10560028 10.1016/S0006-3223(99)00192-4 1:CAS:528:DyaK1MXotVOktrk%3D (Pubitemid 30114440)
8. J Biederman T Spencer T Wilens 2004 Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder Int J Neuropsychopharmacol 7 1 77 97 14733627 10.1017/S1461145703003973 1:CAS:528:DC%2BD2cXhtlKgs7c%3D (Pubitemid 38523811)
9. L Bizarro S Patel C Murtagh IP Stolerman 2004 Differential effects of psychomotor stimulants on attentional performance in rats: nicotine, amphetamine, caffeine and methylphenidate Behav Pharmacol 15 3 195 206 15187577 1:CAS:528:DC%2BD2cXks1Khtbo%3D (Pubitemid 38859602)
10. C Blondeau F Dellu-Hagedorn 2007 Dimensional analysis of ADHD subtypes in rats Biol Psychiatry 61 12 1340 1350 17054922 10.1016/j.biopsych.2006.06.030 (Pubitemid 46855765)
11. RM Booze DR Wallace 1995 Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride Synapse 19 1 1 13 7709338 10.1002/syn.890190102 1:CAS:528:DyaK2MXjt1OntLw%3D
12. M Bouthenet E Souil M Martres P Sokoloff B Giros J Schwartz 1991 Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA Brain Res 564 2 203 219 10.1016/0006-8993(91)91456-B 1839781 10.1016/0006-8993(91) 91456-B 1:CAS:528:DyaK38Xhs1Wktg%3D%3D
13. FP Bymaster JS Katner DL Nelson SK Hemrick-Luecke PG Threlkeld JH Heiligenstein SM Morin, et al. 2002 Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder Neuropsychopharmacology 27 5 699 711 12431845 10.1016/S0893-133X(02)00346-9 1:CAS:528:DC%2BD38Xoslyitb8%3D (Pubitemid 35335888)
14. J Caballero MC Nahata 2003 Atomoxetine hydrochloride for the treatment of attention-deficit/hyperactivity disorder Clin Ther 25 12 3065 3083 14749146 10.1016/S0149-2918(03)90092-0 1:CAS:528:DC%2BD2cXhsVSnsrY%3D (Pubitemid 38096145)
15. SR Chamberlain N Del Campo J Dowson U Müller L Clark TW Robbins BJ Sahakian 2007 Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder Biol Psychiatry 62 9 977 984 17644072 10.1016/j.biopsych.2007.03.003 1:CAS:528:DC%2BD2sXhtF2htbfL (Pubitemid 47562368)
16. SR Chamberlain BJ Sahakian 2007 The neuropsychiatry of impulsivity Curr Opin Psychiatry 20 3 255 261 17415079 (Pubitemid 46588298)
17. L Chiodo M Bannon A Grace R Roth B Bunney 1984 Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons Neuroscience 12 1 1 16 6462443 10.1016/0306-4522(84)90133-7 1:CAS:528:DyaL2cXkvVCnt7k%3D (Pubitemid 14077673)
18. EJ Curran SJ Watson 1995 Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens o the rat: a double in situ hybridization study J Comp Neurol 361 1 57 76 8550882 10.1002/cne.903610106 1:CAS:528:DyaK2MXptFShs7c%3D
19. JW Dalley BJ Everitt TW Robbins 2011 Impulsivity, compulsivity, and top-down cognitive control Neuron 69 4 680 694 21338879 10.1016/j.neuron.2011. 01.020 1:CAS:528:DC%2BC3MXit1Kntbo%3D
20. JW Dalley TD Fryer L Brichard ESJ Robinson DEH Theobald K Laane Y Pena, et al. 2007 Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement Science 315 5816 1267 1270 17332411 10.1126/science. 1137073 1:CAS:528:DC%2BD2sXitFChsrk%3D (Pubitemid 46364262)
21. L Diergaarde T Pattij L Nawijn AN Schoffelmeer TJ De Vries 2009 Trait impulsivity predicts escalation of sucrose seeking and hypersensitivity to sucrose-associated stimuli Behav Neurosci 123 4 794 803 19634937 10.1037/a0016504 1:CAS:528:DC%2BC3cXltF2rsrs%3D
22. L Diergaarde T Pattij I Poortvliet F Hogenboom W de Vries ANM Schoffelmeer TJ De Vries 2008 Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in rats Biol Psychiatry 63 3 301 308 17884016 10.1016/j.biopsych.2007.07.011 1:CAS:528: DC%2BD1cXlsVWntA%3D%3D
23. DD Dougherty AA Bonab TJ Spencer SL Rauch BK Madras AJ Fischman 1999 Dopamine transporter density in patients with attention deficit hyperactivity disorder Lancet 354 9196 2132 2133 10609822 10.1016/S0140-6736(99)04030-1 1:CAS:528:DC%2BD3cXnt1Crug%3D%3D (Pubitemid 30008900)
24. D Economidou Y Pelloux TW Robbins JW Dalley BJ Everitt 2009 High impulsivity predicts relapse to cocaine-seeking after punishment-induced abstinence Biol Psychiatry 65 10 851 856 19181308 10.1016/j.biopsych.2008.12.008 1:CAS:528:DC%2BD1MXltFWnsL8%3D
25. J Elia PJ Ambrosini JL Rapoport 1999 Treatment of attention-deficit- hyperactivity disorder N Engl J Med 340 10 780 788 10072414 10.1056/ NEJM199903113401007 1:STN:280:DyaK1M7ls1entA%3D%3D (Pubitemid 29114298)
26. M Ernst AJ Zametkin JA Matochik PH Jons RM Cohen 1998 DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study J Neurosci 18 15 5901 5907 9671677 1:CAS:528:DyaK1cXkvFWnsL0%3D (Pubitemid 28341366)
27. ABP Fernando TW Robbins 2011 Animal models of neuropsychiatric disorders Annu Rev Clin Psychol 7 1 110301095455042 10.1146/annurev-clinpsy-032210-104454
28. JS Franowicz LE Kessler CMD Borja BK Kobilka LE Limbird AFT Arnsten 2002 Mutation of the alpha 2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine J Neurosci 22 19 8771 8777 12351753 1:CAS:528:DC%2BD38Xns1CisLc%3D (Pubitemid 35387619)
29. MM van Gaalen R van Koten AN Schoffelmeer LJ Vanderschuren 2006 Critical involvement of dopaminergic neurotransmission in impulsive decision making Biol Psychiatry 60 1 66 73 16125144 10.1016/j.biopsych.2005.06.005
30. RE Heikkila L Manzino 1984 Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake Eur J Pharmacol 103 3-4 241 248 6237922 10.1016/0014-2999(84)90483-7 1:CAS:528:DyaL2cXlvVert7c%3D (Pubitemid 14028979)
31. CJ Kratochvil JH Heiligenstein R Dittmann TJ Spencer J Biedernan J Wernicke JH Newcorn, et al. 2002 Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial J Am Acad Child Adolesc Psychiatry 41 7 776 784 12108801 10.1097/00004583-200207000-00008 (Pubitemid 38338092)
32. K Krause SH Dresel J Krause HF Kung K Tatsch 2000 Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography Neurosci Lett 285 2 107 110 10793238 10.1016/S0304-3940(00) 01040-5 1:CAS:528:DC%2BD3cXivVGgurk%3D (Pubitemid 30227631)
33. S Kutcher M Aman SJ Brooks J Buitelaar E van Daalen J Fegert RL Findling, et al. 2004 International consensus statement on attention-deficit/ hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions Eur Neuropsychopharmacol 14 1 11 28 14659983 10.1016/S0924-977X(03)00045-2 1:CAS:528:DC%2BD3sXps1Gkur0%3D (Pubitemid 37495027)
34. RB McCall KJ Lookingland PJ Bédard RM Huff 2005 Sumanirole, a highly dopamine D2-selective receptor agonist: in vitro and in vivo pharmacological characterization and efficacy in animal models of Parkinson's disease J Pharmacol Exp Ther 314 3 1248 1256 15980060 10.1124/jpet.105.084202 1:CAS:528:DC%2BD2MXpvFSqsLc%3D (Pubitemid 41205991)
35. CR McKittrick ED Abercrombie 2007 Catecholamine mapping within nucleus accumbens: differences in basal and amphetamine-stimulated efflux of norepinephrine and dopamine in shell and core J Neurochem 100 5 1247 1256 17241132 10.1111/j.1471-4159.2006.04300.x 1:CAS:528:DC%2BD2sXjt1Grsr8%3D
36. JA Milstein JW Dalley TW Robbins 2010 Methylphenidate-induced impulsivity: pharmacological antagonism by beta-adrenoreceptor blockade J Psychopharmacol 24 3 309 321 19074531 10.1177/0269881108098146 1:CAS:528:DC%2BC3cXkslSgtbc%3D
37. FG Moeller ES Barratt DM Dougherty JM Schmitz AC Swann 2001 Psychiatric aspects of impulsivity Am J Psychiatry 158 11 1783 1793 11691682 10.1176/appi.ajp.158.11.1783 1:STN:280:DC%2BD3MnktVenug%3D%3D (Pubitemid 33054770)
38. R Navarra R Graf Y Huang S Logue T Comery Z Hughes M Day 2008 Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test Prog Neuropsychopharmacol Biol Psychiatry 32 1 34 41 17714843 10.1016/j.pnpbp.2007.06.017 1:CAS:528:DC%2BD1cXptlaitg%3D%3D
39. JH Newcorn JM Halperin PS Jensen HB Abikoff LE Arnold DP Cantwell CK Conners, et al. 2001 Symptom profiles in children with ADHD: effects of comorbidity and gender J Am Acad Child Adolesc Psychiatry 40 2 137 146 11214601 10.1097/00004583-200102000-00008 1:STN:280:DC%2BD3M7ktFCnsw%3D%3D (Pubitemid 32111017)
40. T Pattij MC Janssen LJ Vanderschuren AN Schoffelmeer MM van Gaalen 2007 Involvement of dopamine D1 and D2 receptors in the nucleus accumbens core and shell in inhibitory response control Psychopharmacology 191 3 587 598 16972104 10.1007/s00213-006-0533-x 1:CAS:528:DC%2BD2sXitlCqtLg%3D (Pubitemid 46355887)
41. MA Pezze JW Dalley TW Robbins 2009 Remediation of attentional dysfunction in rats with lesions of the medial prefrontal cortex by intra-accumbens administration of the dopamine D2/3 receptor antagonist sulpiride Psychopharmacology 202 1-3 307 313 18985321 10.1007/s00213-008-1384-4 1:CAS:528:DC%2BD1cXhtlalu73I
42. MA Pezze JW Dalley TW Robbins 2007 Differential roles of dopamine D1 and D2 receptors in the nucleus accumbens in attentional performance on the five-choice serial reaction time task Neuropsychopharmacology 32 2 273 83 16641946 10.1038/sj.npp.1301073 1:CAS:528:DC%2BD2sXlt12qtw%3D%3D (Pubitemid 46106934)
43. MN Potenza 2007 To do or not to do? The complexities of addiction, motivation, self-control, and impulsivity Am J Psychiatry 164 1 4 6 17202534 10.1176/appi.ajp.164.1.4 (Pubitemid 46154771)
44. TT Puumala S Ruotsalainen P Jakala E Koivisto P Riekkinen Jr J Sirvio 1996 Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder Neurobiol Learn Mem 66 198 211 8946412 10.1006/nlme.1996.0060 1:CAS:528:DyaK2sXisVWmtg%3D%3D (Pubitemid 26423879)
45. TW Robbins 2002 The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry Psychopharmacology 163 362 380 12373437 10.1007/s00213-002-1154-7 1:CAS:528:DC%2BD38XnsFymurc%3D
46. TW Robbins BJ Everitt 2007 A role for mesencephalic dopamine in activation: commentary on Berridge (2006) Psychopharmacology 191 3 433 437 16977476 10.1007/s00213-006-0528-7 1:CAS:528:DC%2BD2sXitlCqtLY%3D (Pubitemid 46355885)
47. TW Robbins BJ Sahakian 1979 "Paradoxical" effects of psychomotor stimulant drugs in hyperactive children from the standpoint of behavioural pharmacology Neuropharmacology 18 12 931 950 43484 10.1016/0028-3908(79)90157-6 1:CAS:528:DyaL3cXhsVSlurs%3D (Pubitemid 10117383)
48. E Robinson D Eagle D Economidou D Theobald A Mar E Murphy T Robbins, et al. 2009 Behavioural characterisation of high impulsivity on the 5-choice serial reaction time task: specific deficits in 'waiting' versus 'stopping' Behav Brain Res 196 2 310 316 18940201 10.1016/j.bbr.2008.09.021 1:STN:280: DC%2BD1M%2FhvV2gsg%3D%3D
49. ESJ Robinson DM Eagle AC Mar A Bari G Banerjee X Jiang JW Dalley, et al. 2008 Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat Neuropsychopharmacology 33 5 1028 1037 17637611 10.1038/sj.npp.1301487 1:CAS:528:DC%2BD1cXjtFOhtLk%3D (Pubitemid 351367544)
50. T Roman LA Rohde MH Hutz 2004 Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit- hyperactivity disorder Am J Pharmacogenomics 4 2 83 92 15059031 10.2165/00129785-200404020-00003 1:CAS:528:DC%2BD2cXksFWru74%3D (Pubitemid 38560315)
51. 2 receptor agonist PNU-95666E from d-phenylalanine using a sequential oxidative cyclization strategy J Org Chem 62 6582 6587 10.1021/jo970526a 1:CAS:528:DyaK2sXmtVehsbc%3D (Pubitemid 127493028)
52. T Sagvolden 2006 The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of attention-deficit/hyperactivity disorder (ADHD) Behav Brain Funct 2 41 41 17173664 10.1186/1744-9081-2-41 (Pubitemid 46195490)
53. L Scahill PB Chappell YS Kim RT Schultz L Katsovich E Shepherd AF Arnsten, et al. 2001 A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder Am J Psychiatry 158 7 1067 1074 11431228 10.1176/appi.ajp.158.7.1067 1:STN:280:DC%2BD3MznsVegtQ%3D%3D (Pubitemid 32623110)
54. Y Schmitz C Schmauss D Sulzer 2002 Altered dopamine release and uptake kinetics in mice lacking D2 receptors J Neurosci 22 18 8002 8009 12223553 1:CAS:528:DC%2BD38Xnt12ksLc%3D (Pubitemid 35379105)
55. MV Solanto 2002 Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research Behav Brain Res 130 1-2 65 71 11864719 10.1016/S0166-4328(01)00431-4 1:CAS:528:DC%2BD38XhsFaksrs%3D (Pubitemid 34195322)
56. ND Volkow G Wang SH Kollins TL Wigal JH Newcorn F Telang JS Fowler, et al. 2009 Evaluating dopamine reward pathway in ADHD: clinical implications JAMA 302 10 1084 1091 19738093 10.1001/jama.2009.1308 1:CAS:528:DC%2BD1MXhtFaqurvJ
57. CA Winstanley FD Zeeb A Bedard K Fu B Lai C Steele AC Wong 2010 Dopaminergic modulation of the orbitofrontal cortex affects attention, motivation and impulsive responding in rats performing the five-choice serial reaction time task Behav Brain Res 210 2 263 272 20206211 10.1016/j.bbr.2010.02. 044 1:CAS:528:DC%2BC3cXlsFaqs7k%3D
58. L Yang Y Wang J Li SV Faraone 2004 Association of norepinephrine transporter gene with methylphenidate response J Am Acad Child Adolesc Psychiatry 43 9 1154 1158 15322419 10.1097/01.chi.0000131134.63368.46 (Pubitemid 39096873)